Cancer Research Uk
PowderMed (Oxford, UK) and Ludwig Institute for Cancer Research (London, UK) began a Phase I trial for a DNA cancer vaccine of Herpes Simplex Type 2.(Phase I) PowderMed (Oxford, UK) and Ludwig Institute for Cancer Research (London, UK) began a Phase I trial for ...
|
